SynthesisAnnals of the rheumatic diseases2003

Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis.

M C Hochberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.